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We previously showed that topical flagellin induces profound mucosal innate protection
in the cornea against microbial infection, a response involving multiple genes and cell
types. In this study, we used a Candida albicans (CA)-C57BL/6 mouse keratitis model to
delineate the contribution of CXCL10- and CXCR3-expressing cells in flagellin-induced
protection. Flagellin pretreatment markedly enhanced CXCL10 expression at 6 h post CA
infection (hpi), but significantly dampened CXCL10 expression at 24 hpi. At the cellu-
lar level, CXCL10 was expressed in the epithelia at 6 hpi in flagellin-pretreated corneas,
and concentrated at lesion sites 24 hpi. CXCR3-expressing cells were detected in great
numbers at 24 hpi, organized within clusters at the lesion sites in CA-infected corneas.
CXCL10 or CXCR3 neutralization increased keratitis severity and dampened flagellin-
induced protection. CXCR3-positive cells were identified as NK cells, the depletion of
which resulted in severe CA keratitis. Contributions from NK T-cells were excluded by
finding no change in flagellin-induced protection in Rag1 KO mice. Recombinant CXCL10
inhibited CA growth in vitro and accelerated fungal clearance and inflammation resolu-
tion in vivo. Taken together, our data indicate that epithelium-expressed CXCL10 plays
a critical role in fungal clearance and that CXCR3-expressing NK cells contribute to CA
eradication in mouse corneas.
Keywords: Antimicrobial peptides  CXCL10  Fungal keratitis  Innate immunity  Natural
killer cells
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Correspondence: Dr. Fu-Shin X. Yu
e-mail: fyu@med.wayne.edu
Introduction
Candida albicans (CA) is a commensal fungus of the normal flora,
yet may cause opportunistic infections of the cornea following
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trauma or surgery, during periods of immunosuppression such
as prolonged corticosteroid use, and during topical anesthetic
abuse [1–6]. Although rare, the incidence of fungal keratitis
has increased in recent years, especially in contact lens wearers
[7, 8]. To date, there is no clinically amenable measure to prevent
fungal keratitis. Current practice in treating fungal keratitis
involves the use of topical antifungal drops such as natamycin
and amphotericin B. Topical antifungals can cause toxicity such
as punctate keratitis, chemosis, and recurrent corneal epithelial
erosions [9]. Hence, understanding the pathogenesis of fungal
keratitis and host responses will aid in identifying new therapeu-
tics to improve the prognosis of this condition.
Using various murine models of fungal keratitis, recent
research indicates that innate immunity, primarily mediated by
various TLRs and the MyD88 signaling pathway, plays a key role
in the host response to fungal infection [10, 11]. We have devel-
oped a mouse experimental CA keratitis model [12, 13] to show
that pre-exposure of the cornea to TLR5 ligand flagellin induces a
strong innate defense and promotes robust resistance to infection
in the cornea [14]. The activation of innate immunity after TLR5
stimulation is attributed to flagellin-induced reprogramming of
gene expression in corneal epithelial cells (CECs) in response to
pathogens, including diminished inflammatory response to CA and
at the same time, enhanced production of antimicrobial peptides
(AMPs) in a TLR5-dependentmanner [14–17]. Our data suggested
that topical applied flagellin functions as an immunostimulant to
activate the innate defense apparatus, resulting in resistance to
infectious keratitis [14, 18, 19]. More recently, we have shown
that flagellin pretreatment followed by Pseudomonas (P) aerugi-
nosa infection resulted in 890 genes upregulated and 37 genes
downregulated [17]. At the cell levels, neutrophils were shown to
be required for flagellin-induced protection against P. aeruginosa
and CA [14, 19]. The depletion of neutrophils resulted in P. aerug-
inosa dissemination from the eye to the entire body and in death
within 2 dpi and in corneal perforation in otherwise self-healing,
CA-infected corneas of C57BL/6 mice [14, 19]. Others have shown
the importance of macrophages in corneal defense against fungal
and bacterial pathogens [20, 21]. Hence, flagellin-induced protec-
tion may have the participation of most, if not all, innate immune
cell types as well as the participation of residential CECs and
stromal fibroblasts. As flagellin, a virulent Gram-negative protein,
is unlikely to be used clinically, identifying the downstream effec-
tors that participate in flagellin-induced fungus killing is of great
importance.
In an effort to study transcriptional regulation, we identified
interferon regulatory factor 1 (IRF1) as one of the most highly
upregulated transcription factors in response to P. aeruginosa
infections in vitro and in vivo [22]. We showed that IRF1, by reg-
ulating CXCL10 expression, plays a role in corneal innate immune
response. Moreover, we identified IFN-γ produced by NK cells
as a key factor that augmented IRF1 and CXCL10 expression
in flagellin-pretreated corneas [22]. In another study, we also
reported great upregulation of CXCL10 in response to epithelial
wounding in a DC-related manner in mouse CECs [17]. CXCL10
is a member of the IFN-inducible tripeptide motif Glu-Leu-Arg-
negative (ELR−) CXC chemokines [23]. This chemokine, along
with CXCL9 and CXCL11, signals through a G-protein-coupled
receptor, CXCR3 that is expressed primarily on activated T lym-
phocytes and NK cells, and functions primarily in the recruitment
of these cells to the sites of infection and inflammation [24–26].
In addition to their roles in leukocyte recruitment, CXCR3 ligands
exert direct antimicrobial effects that are comparable to the effects
mediated by cationic AMPs, including defensins [27]. To date,
whether CXCL10 participates in corneal innate defense against
fungal infection remains to be determined.
In this study, we sought to better understand the molecular
mechanisms underlying flagellin-induced protection and corneal
innate immunity using an experimental Candida keratitis model.
We showed that while CXCL10 was mostly expressed in CECs,
especially at the early stage of infection, CXCR3 was expressed
only in the infiltrating cells, most of which were NK1.1-positive.
Neutralizing CXCL10, CXCR3 or depleting NK cells impaired
innate defense against CA in the cornea. Our results reveal that
the CXCL10-CXCR3 signaling pathway plays a role in mucosal
innate immunity against fungal infection and that CXCL10
might be developed as an adjuvant treatment for microbial
keratitis.
Results
Flagellin-induced protection against CA is T- and
B-cell independent
As flagellin-induced protection can be detected as early as 6 hpi
(where hpi is hours post CA infection) and was very apparent
at 24 hpi, and the outcome of infectious keratitis was strongly
related to the pathogen load at 1 dpi [14, 19, 28], we suspect that
the protection is mostly related to innate immunity. To test this
hypothesis, we used Rag1 KO (Rag1KO mice that lack all T cells
and B cells, in comparison with WT C57BL/6 mice, to determine
the role of adaptive immunity in flagellin induced protection. We
previously showed that 105 CA (human isolate strain SC5314) was
sufficient to cause fungal keratitis in C57BL/6mice [14]. Figure 1A
shows a normal C57BL/6 mouse eye, and eyes infected with CA
at 24 hpi, with or without flagellin pretreatment. The protective
effects of flagellin pretreatment were evident by the presence of
small areas of opacification in flagellin-pretreated eyes, whereas
the control-infected cornea (PBS) was 50% covered with patches
of opacification. The severity of keratitis under different experi-
mental conditions was quantitated with clinical scoring. The CA
keratitis in C57BL/6 mice was moderate at 1 dpi and exhibited
mild eye diseases at 5 dpi. There were no differences in clinical
scores, opacification of the cornea, PMN infiltration indicated by
myeloperoxidase (MPO) enzyme activities, and the expression of
proinflammatory cytokine CXCL2 between Rag1KO and C57BL/6
mice. The flagellin-pretreated corneas in these mice remained
keratitis free at 5 dpi. Thus, we conclude that flagellin-induced
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Figure 1. Flagellin inducesmucosal protection against C. Albicans in an innate immunity-dependentmanner. (A) The centers of C57BL/6 or Rag1−/−
mouse corneas were gently scratched with 26-gauge needles (three scratches, each 1 mm long) followed by topical application of 500 ng flagellin
in 5 μL PBS or 5 μL PBS alone to the injury sites. Corneas were then scratched again 24 h after pretreatment and inoculated with 1.0 × 105 CFU of
CA. A naı¨ve cornea (normal), CA-infected cornea with flagellin (flag), and the control (PBS) pretreated CA-infected cornea were photographed at
1 or 5 dpi with a slit lamp. One representative image for each condition (n = 5) is presented. (B) Disease severity was assessed in mice treated as
in (A) and is represented by clinical scores performed at 1, 3, and 5 dpi. The horizontal line represents the mean clinical score. A nonparametric
Mann–Whitney U-test was performed to compare each flagellin pretreatment to the PBS group (**p < 0.01, n = 5). (C) Four WT C57BL/6 and three
Rag1−/− mice, treated as in (A), were euthanized at 1 dpi. The corneas were excised and subjected to fungal plate counting with the results
presented as CFU CA per cornea. Each symbol represents an individual mouse and means ± SD are indicated. (D) Myeloperoxidase determination
(units/cornea) and (E) CXCL10 ELISA were performed at 1 day postinfection in mice treated with or without flagellin. (D and E) Data are shown as
means + SD of five samples and (B–E) are representative of two independent experiments.
protection does not require functional B or T cells, but rather
primarily involves innate immune cells, including neutrophils
[14, 19] and NK cells.
Flagellin pretreatment regulates Cxcl10 and Cxcr3
expression in corneas in response to CA infection
Our recent study of P. aeruginosa keratitis identified CXCL10 as
a major chemokine induced by infection and augmented by flag-
ellin pretreatment in an IFN-γ and IRF1-dependent manner [22].
To determine if CXCL0 also plays a role in corneal innate defense
against fungal pathogens, we assessed the expression of Cxcl10
and its receptor Cxcr3 in response to fungal infection, with or
without flagellin pretreatment (Fig. 2). In normal, homeostatic
corneas (NL), no expression of Cxcl10 and Cxcr3 was detected.
Flagellin-pretreated, but not PBS-instilled, corneas expressed
detectable Cxcl10 and Cxcr3 at 24 h posttreatment, prior to
pathogen inoculation. CA infection triggered the expression of
both Cxcl10 and Cxcr3, and flagellin pretreatment had disparate
effects on the expression of Cxcr3 (downregulated) and Cxcl10
(upregulated) in C57BL/6 mouse corneas at 6 hpi. At 24 hpi,
both Cxcl10 and Cxcr3 were more abundant in C. albicans infected
corneas, but flagellin pretreatment dampened their expression
(Fig. 2A). Robust upregulation of Cxcl10, but not other Cxcr3
ligands, Cxcl9 and Cxcl11, and Cxcr3 in response to infection, and
their suppression by flagellin pretreatment, were also detected by
real-time PCR (Fig. 2B). The dramatic downregulation of Cxcl10
and Cxcr3 in flagellin-pretreated corneas was consistent with a
lack of any sign of infection and/or inflammation in the treated
corneas at 1 dpi shown in Figure 1.
Flagellin pretreatment alters CXCL10-CXCR3 signaling
by increasing the expression of CXCL10
We next investigated if Cxcl10 and Cxcr3 were expressed at
the protein level and how they were distributed in CA-infected
corneas, with or without flagellin pretreatment, using immuno-
histochemistry (Fig. 3). No CXCL10- or CXCR3-positive cells were
detected in the normal, homeostatic corneas (Fig. 3A). Flagellin
pretreatment through topical application to needle injury sites
(Fig. 3C), but not injury itself (Fig. 3B), was sufficient to induce
the expression of CXCL10 at the basal cell layer of the stratified
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Figure 2. Topical flagellin affects expression of Cxcl10 and Cxcr3
in C57BL/6 mouse corneas. C57BL/6 mouse corneas were flagellin-
pretreated and CA-inoculated as described in Figure 1. The naı¨ve (NL)
and CA-infected corneas with or without flagellin pretreatment for
24 h were excised at 0 (no fungal inoculation, 0 h), 6, and 24 hpi, and
subjected to (A) RNA isolation and RT-PCR analysis for Cxcl10 (L10) and
Cxcr3 (R3), with Gapdh (G3) as an internal control or (B) real-time PCR
for Cxcl9, Cxcl10, Cxcl11, and Cxcr3. The fold increase over that of the
naı¨ve corneas (value 1) in (B) is the mean + SD of three samples for
each condition with β-actin as the internal control for normalization.
The results are representatives of two independent experiments.
epithelia and of CXCR3 underneath the epithelial layer, suggest-
ing paracrine signaling. At 6 hpi, there was a clear increase of
CXCL10 in all epithelial cell layers in CA-infected corneas with a
few CXCR3-positive cells in the stroma (Fig. 3D). Consistent with
the PCR results, flagellin pretreatment augmented CA-induced
CXCL10 expression in all CECs, with a few cells strongly express-
ing CXCR3 in the stroma (Fig. 3E) at 6 hpi. At 24 hpi, epithe-
lial lesions were detected in the infected corneas. In the control,
PBS-treated corneas, there was a large lesion with reduced epithe-
lial cell layers. The CECs surrounding the lesion expressed high
levels of CXCL10, while CXCR3-positive cells, many of which were
in clusters, were primarily detected in the stroma (Fig. 3F). In
flagellin-pretreated corneas at 24 hpi, a portion of the epithe-
lium became thicker, assumed to be the entering site of invading
CA; there were strongly CXCL10-stained cells (CXCL10high) in the
epithelial layer, many of which were at the apical side of the
thickening site, and in the stroma, mostly at the posterior side.
A cluster of CXCR3-positive cells was inserted into the epithe-
lium (Fig. 3G). In both CA-infected corneas with or without flag-
ellin pretreatment at 24 hpi, CXCR3-positive cells were only found
where epithelial lesions or abnormalities were detected. The over-
all staining intensity of CXCL10 and CXCR3 in flagellin-pretreated
corneas (Fig. 3G) is much less than that in the control (Fig. 3F) at
24 hpi. The expression patterns of CXCL10 and CXCR3 detected
by immunohistochemistry were consistent with that detected by
real-time PCR (Fig. 2B).
CXCL3-positive cells around lesion sites are
CXCL10-positive NK cells
We next investigated cell type(s) that express CXCL10 and CXCR3
in CA-infected corneas with or without flagellin pretreatment
(Fig. 4). Our previous work revealed that neutrophils play a key
role in eradicating invading pathogens, including CA [14, 19].
To assess the potential involvement of other innate immune
cells, such as NK, macrophages, and DCs in fungal keratitis, we
prescreened CA-infected corneal sections and found that among
these cell types, NK1.1-positive cells exhibited a similar stain-
ing pattern of CXCL3-positive cells. As such, we used dou-
ble immunofluorescence staining to determine if indeed those
CXCL10- and/or CXCR3-positive cells were also NK1.1-positive
in CA-infected corneas. In the control, CA-infected corneas at 24
hpi, CECs were CXCL10-positive whereas CXCL10high cells were
found to surround a small epithelial lesion site with a large clus-
ter of CXCL10high cells on top of the epithelium and in the stroma
underneath the epithelial layer (arrows, Fig. 4A, i). NK1.1 staining
was totally negative for CECs, while NK1.1-positive cells showed
an identical localization of CXCL10high cells in the epithelium as
well as in the stroma (Fig. 4A, iii and v). In flagellin-pretreated
corneas, CXCL10 was expressed in the epithelium and in some
stroma cells (Fig. 4A, ii); the density of NK1.1-positive cells was
low and located primarily at the posterior side of the stroma
(Fig. 4A, iv); and the distribution of these NK1.1-positive cells
matched well with the CXCL10high cells (Fig. 4A, ii and vi). There
were cells in the stroma that were CXCL10-positive (arrowheads),
but NK1.1-negative.
In CXCR3 and NK1.1 double-stained sections, CXCR3-positive
cells in the stroma and epithelium (arrowhead) were also NK1.1-
positive (Fig. 4B, i, iii, and v). In flagellin-pretreated corneas, all
CXCR3-positive cells were NK1.1-positive (Fig. 4B, ii, iv, and vi). It
should bementioned that NK1.1-positive cells were mostly located
at or near lesion sites in CA-infected corneas. Taken together, since
we excluded contamination with conventional T cells, including
NK T-cells through the use of Rag1−/− mice [29, 30], we concluded
that the infiltrated cells expressing CXCR3 are NK cells.
CXCL10-CXCR3-mediated signaling is required for
fungal clearance in the cornea
Having shown that both CXCL10 and CXCR3 were expressed in
CA-infected corneas at 24 hpi, we next investigated if CXCL10
functions as an AMP or as a signaling molecule that involves its
receptor CXCR3 by Ab-mediated functional neutralization (Fig. 5).
The CXCL10 or CXCR3 neutralizing antibodies, along with control
rabbit IgG, were injected into subconjunctival spaces 4 h prior
to flagellin pretreatment for 24 h, followed by CA inoculation.
As shown in Figure 5, the corneas of the control (unspecific IgG
injected, PBS instilled corneas) were partially coveredwith opacifi-
cation at 1 dpi while flagellin pretreatment protected the C57BL/6
mouse corneas from CA infection (Fig. 5A). The CXCL10- or
CXCR3-neutralized corneas had much more severe keratitis, with
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Figure 3. CXCL10 and CXCR3 expression and distribution in CA-infected corneas with or without flagellin pretreatment. C57BL/6 mouse corneas
were pretreated with or without topical flagellin for 24 h, followed by CA inoculation as described in Figure 1. At 0 (no bacterial inoculation), 6,
and 24 h postinoculation, corneas (n = 3 for each condition) were collected, embedded in Optimal Cutting Temperature (OCT), and sectioned. The
sections were subjected to immunohistochemical analysis with rabbit anti-mouse CXCL10 (1:100), with DAPI staining for nuclei of the same section
at left and CXCR3 (1:250) with DAPI staining at right. Arrowheads indicate positive cell clusters. Two independent experiments were performed,
one representative image for each condition is presented.
the whole corneas covered with opacification of different intensity
in the control mice. Moreover, there was also partial corneal
melting (arrows, Fig. 5A) in CXCL10- or CXCR3-neutralized
corneas, with clinical scores >10, indicating severe
keratitis (Fig. 5B). While flagellin-induced protection was
diminished when CXCL10 or CXCR3 were neutralized, the
severity of keratitis was less in the flagellin-pretreated corneas
compared with the counterparts of the control, PBS-treated
ones, with clinical scores of approximately 6 (moderate ker-
atitis). Consistent with the severity of keratitis, both CXCL10-
and CXCR3-neutralized corneas had much greater numbers
of CA compared with IgG-injected corneas. Surprisingly,
neutralizing CXCR3 had a significantly higher fungal burden
(Fig. 5C) while exhibiting similar effects on PMN infiltration
(Fig. 5D) and CXCL2 expression (Fig. 5E), compared to CXCL10
neutralized.
NK cells are important for corneal innate defense
against CA infection
Since NK cells expressed CXCR3, we next investigated the role
of NK cells in fungal clearance and PMN infiltration by the sub-
conjunctival injection of NK1.1-neutralizing Ab (Fig. 6). Corneas
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Figure 4. Cell-type determination of infiltrated cells expressingCXCL10
and CXCR3. C57BL/6 mouse corneas (n = 3 for each condition)
were pretreated with (ii, iv, vi subpanels in (A) and (B)) or without
(i, iii, v subpanels in (A) and (B)) topical flagellin for 24 h, followed by
CA inoculation as described in Figure 1, then stained with (A) CXCL10
or (B) CXCR3 and co-stained with NK1.1 (green) antibodies. Arrowhead
indicates co-localized cells. Three independent experiments were per-
formed, one representative image for each condition is presented.
injected with NK1.1 had much more severe keratitis (Fig. 6A) at
1 dpi, with opacification covering the entire cornea, severe ocular
surface irregularity, signs of inflammation in aqueous humor, and
neovascularization. The much small size of NK1.1-treated eyes
was indicative of the cornea near perforation. Figure 6B showed
that the subconjunctival injection of NK1.1 greatly reduced the
number of cells expressing CXCR3; the staining intensity of these
CXCR3-positive infiltrated cells (Fig. 6B, i and ii) was also rela-
tively lower compared with IgG-treated corneas, suggesting the
reduction or depletion of NK cells. The NK1.1-treated cornea
sections were stainedwith FITC-labeled NK1.1, four lightly stained
cells were detected (arrows, Fig. 6B, iv) in NK1.1-treated corneas
while large number of NK1.1-positive cells were observed in IgG-
injected controls (Fig. 6B, iii). Thus, the subconjunctival injec-
tion of NK1.1 resulted in the depletion of NK cells. Functionally,
NK-cell depletion resulted in great thinning of the cornea (ulcera-
tion, Fig. 6B, ii and iv), consistent with the average clinical score
>10 (Fig. 6C), indicating severe keratitis. Plate counting revealed
a small increase in fungal burden in NK-cell depleted corneas
(1.37-fold) (Fig. 6D). PMN infiltration determined by MPO assay
was also significantly higher in NK-depleted corneas (Fig. 6E).
Taken together, NK-cell depletion resulted in severe fungal kerati-
tis in C57BL/6 mouse corneas.
In vitro fungicidal activity of CXCL10
CXCR3 ligands have been shown to possess the ability to kill
microorganisms, mostly bacteria [23, 31, 32]. To determine
if CXCL10 can kill CA, as demonstrated for CCL20 [32], we
performed in vitro fungus killing assay and found that under phys-
iological condition (PBS), recombinant human CXCL10 killed CA
in a concentration-dependent manner (Fig. 7).
Recombinant CXCL10 dampens CA keratitis
As flagellin-induced protection was associated with the endoge-
nous expression of CXCL10, and human CXCL10 is capable of
killing CA in vitro, we next investigated whether exogenous
CXCL10 can be used to protect corneas from fungal keratitis. Two
routes of application were used. In one group, CXCL10 (500 ng in
5 μL) was subconjunctivally injected into mice with PBS solution
as the control 4 h prior to CA inoculation, followed by the topical
application of 5 μL PBS with or without 100 ng CXCL10 at 4 hpi
(Fig. 8). At 1 dpi, the PBS-treated eyes showed keratitis, whereas
the CXCL10-treated corneas exhibited low levels of inflamma-
tion with a few small and faint areas of opacification (Fig. 8A).
Moreover, exogenous CXCL10 significantly decreased the fungal
burden (Fig. 8B), PMN infiltration (Fig. 8C), and CXCL2 expres-
sion (Fig. 8E) at 1 dpi.
In the second group, CXCL10 was dissolved in Soothe emol-
lient eye drops for extended retention at the ocular surface; 5 μL
containing 25 ng/μL CXCL10 was topically applied to the infected
corneas starting at 6 hpi, five times for the first day and three
times daily until day 7. Figure 9 shows the images of infected
corneas at day 3, 5, and 7 after CXCL10 treatment (dpt). At 3
dpt (88 h postinfection), the control, Soothe instilled corneas,
displayed dense opacification localized near the center of the
cornea, while the CXCL10-treated cornea had less than half of
the cornea covered with a small central ring of dense opacifi-
cation. At day 5, there was improvement for both conditions. In
Soothe-treated eyes, some peripheral areas were now transparent,
but a central dense opaque area persisted, whereas the density of
opacification in CXCL10-treated eyes was substantially decreased
(Fig. 9A). At 7 dpt, the treated cornea was almost free of diseases,
while the control eye remained in a state of moderate keratitis.
Figure 9B shows the clinical scores of these two groups over 7 days
(n = 5); in each day examined, CXCL10-treated corneas had sig-
nificantly less keratitis than in eyes instilled with Soothe alone.
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Figure 5. CA keratitis occurs upon local neutralization of CXCL10 or CXCR3. C57BL/6 mouse corneas were pretreated with flagellin or PBS at
−24 h, as described in Figure 1. At −6 h, CXCL10- or CXCR3-neutralizing antibodies (2.5 μg/5 μL), with the same dosage of rabbit IgG as the control,
were injected into the subconjunctival space, followed by CA inoculation at 0 h. Eyes were (A) photographed and (B) scored at 24 hpi. (C) Mice were
then euthanized, the corneas were excised and subjected to fungal plate counting with the results presented as CFU (×1000 CA per cornea). In (B)
and (C), each symbol represents an individual mouse and mean ± SD are indicated with horizontal lines. (D) MPO determination (units/cornea)
and (E) CXCL2 ELISA were performed using corneal supernatants. Results in (D) and (E) showmean + SD and are representative of two independent
experiments (n = 5 each) and indicated, *p < 0.05, **p < 0.01 (one-way ANOVA).
Discussion
Using flagellin as an immunostimulant to activate innate immu-
nity and CA as a model pathogen, we report here that both
CXCL10 and CXCR3 become upregulated in the cornea in response
to CA. Flagellin pretreatment resulted in CXCL10 expression
in basal epithelial cells and CXCR3 expression in the subbasal
stroma in uninfected corneas, and in augmented CXCL10 expres-
sion and in the altered distribution of CXCR3-expressing cells
in infected corneas. The highly elevated expression of CXCL10
by flagellin pretreatment may contribute to the elimination
of invading pathogens within CXCL10-expressing epithelium,
Figure 6. CA keratitis with local depletion of NK cells.
Mouse corneas were subconjunctivally injected with
NK1.1 (2.5 μg/5 μL) neutralizing antibodies, with the same
dosage of rabbit IgG as the control, 6 h prior to CA inocula-
tion. (A) Eyes were photographed with a dissection micro-
scope equipped with a digit camera. (B) At 1 dpi, mice
were than euthanized, the corneas were excised and sub-
jected to cryostat sectioning and immunostaining with
FITC-conjugated CXCR3 or NK1.1 antibodies, with DAPI
for nuclear staining. (C) Clinical scoring was performed
to quantitate disease severity. (D) Fungal plate counting
was performed, with the results presented as CFU CA per
cornea. Each symbol represents an individual mouse and
mean ± SD are indicated. (E) MPO determination was per-
formed (units/cornea) and data are shown as means + SD
(n = 5, Student’s t-test). Results are representative of two
independent experiments.
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Figure 7. In vitro fungicidal activity of recombinant and epithelial-
expressed Cxcl10.CA (104 CFU) in 400 μL PBS were incubated with
recombinant human CXCL10 in different concentration for 2 h in
37°C. At the end of incubation, the samples were subjected to fungal
culture and plate-colony counting. The results were presented as CFU
per concentration. Each symbol represents an individual sample and
mean ± SD are indicated. Results are representative of three indepen-
dent experiments. *p < 0.05 (one-way ANOVA).
resulting in enhanced innate immunity and the eradication of
fungal keratitis. However, in untreated, na¨ıve corneas, CXCL10-
CXCR3 signaling and CXCL10-mediated immune cell infiltration
are an important part of mucosal innate defense mechanisms
against CA infection, since the depletion of either one resulted
in more severe keratitis. Using double immunofluorescence
staining, we identified two types of CXCL10-positive cells in
CA-infected corneas: epithelial cells and cells with more abun-
dant CXCL10 that infiltrated both the epithelial and stromal
layers. These CXCL10high cells are also CXCR3- and NK1.1-
positive, indicating that they are NK cells as flagellin-induced
protection was shown not to require any functional T cells
(thus excluding NK T-cells involvement) or B cells. Depleting
NK cells increases fungal keratitis severity. Flagellin pretreat-
ment dampened the infiltration of NK cells and PMN [14],
probably due to reduced pathogen burden (fourfold decrease
at 6 hpi and eightfold decrease at 24 hpi [14]), which con-
sequently reduced the need for infiltrated cells. Finally, we
showed the therapeutic effects of recombinant CXCL10 in pre-
venting corneal infection and in accelerating the resolution of
CA-induced inflammation. Taken together, our study for the
first time reveals that while epithelial CXCL10 is fungicidal, the
CXCL10-CXCR3 signal pathway plays a role in the recruitment
and activation of NK cells, which contribute to innate defense
against CA keratitis.
Our previous studies unraveled a part of the underlying mech-
anisms for flagellin-induced protection, including the persistent
induction of antimicrobial CRAMP (human LL-37 homolog) in
corneal epithelia and the infiltration of a small number of neu-
trophils in the stroma prior to pathogen inoculation [14, 19, 33].
In this study, we demonstrated that flagellin exposure resulted in
the induction of CXCL10 in basal epithelial cells and its recep-
tor CXCR3 underneath the CXCL10-positive cells at the anterior
side of the stroma. Interestingly, we observed that flagellin pre-
treatment enhanced the expression of CXCL10 at the early stage
of infection (6 hpi) but suppressed it at a later stage (24 hpi).
CXCL9, CXCL10, and CXCL11 are chemokines that are rapidly
induced upon infection and upon TLR activation in epithelial
cells, endothelial cells, and monocytes [34, 35]. In this study,
we showed that among the three CXCR3 ligands, only CXCL10 is
expressed in CECs in response to CA infection in C57BL/6 mice.
While CXCL10 expression is augmented, CXCR3 expression was
suppressed by flagellin pretreatment at 6 hpi. Hence, the flagellin-
augmented expression of CXCL10, but not its receptor CXCR3,
is likely the result of reprogramming rather than the additive
effects of flagellin and CA challenge [17]. CXCL10 is a multi-
functional chemokine, exerting direct antimicrobial effects against
bacteria as effective as β-defensin [36, 37]. Whether CXCL10 has
fungicidal activity has not been directly assessed, but it can be
inferred from that of CL20 [32]. In this study, we demonstrate that
Figure 8. Effects of exogenous CXCL10 on CA kerati-
tis. Mouse corneas were subconjunctivally injected with
5 μL PBS with or with 500 ng recombinant Cxcl10
4 h prior to CA inoculation. Eyes were (A) photographed
at 24 hpi with a dissection microscope equipped with
a digital camera and (B) scored. Photographs are rep-
resentative of five corneas each in one of three inde-
pendent experiments. Each symbol in (B) represents an
individual mouse cornea and mean ± SD are shown.
(C) Mice were then euthanized, the corneas were excised
and subjected to fungal plate counting, with the results
presented as CFU CA per cornea. (D) MPO determination
(units/cornea); and (E) CXCL2 measurement (pg/μg cell
extracts) were determined using ELISA. The results in
(C–E) show means + SD (n = 5 each) and are represen-
tative of three independent experiments. **p < 0.01 (Stu-
dent’s t-test).
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Figure 9. Effects of topical, postinfection-applied Cxcl10 on CA kerati-
tis. Mouse corneas were inoculated with 1.0 × 105 CFU of CA at 0 h.
Soothe eye drops with or without 100 ng in 5 μL CXCL10 were instilled
five times at day 1 of the treatment (dpt) starting 6 hpi; in the following
days, three times daily until 7 dpt. (A) The eyes were photographed at
3, 5, and 7 dpt with a slit lamp microscope. Photographs are a repre-
sentative of five corneas. (B) Disease severity is represented by clinical
scores, where each symbol represents an individual sample and hori-
zontal lines represent the mean clinical score ± SD. A nonparametric
Mann–Whitney U-test was performed to compare each CXCL10-treated
to Soothe-instilled group. The results are representative of three inde-
pendent experiments (n = 5 each). **p < 0.01 (Student’s t-test).
recombinant CXCL10 possesses moderate fungicidal activity under
physiological conditions. As significant fungal clearance was
observed at 6 hpi in flagellin-pretreated corneas [17] when the
infiltration of immune cells, particularly CXCR3-positive cells, are
sparse (Fig. 3). Hence, we suggest that although the in vitro fungi-
cidal activity is moderate, the augmented expression of CXCL10
in the epithelium contributes to flagellin-induced innate protec-
tion by direct killing of the fungi at the epithelial layer. This
was confirmed by subconjunctival injection of CXCL10, followed
by a topical application that nearly abolished CA keratitis. Other
AMPs shown to be involved include CRAMP (human LL-37) and
β-defensins [14, 38, 39]. The elimination of invading pathogens
at the early stages of infection induced by flagellin pretreatment
is likely to result in less infiltration of professional immune cells,
including PMN [14], NK cells, macrophages, resulting in reduced
inflammation, and, as such, less or no tissue damage.
CXCL10 signals through CXCR3, and acts primarily in the
recruitment of NK cells and plasmacytoid DCs to the sites of infec-
tion and inflammation [26, 36, 37, 40]. Several studies of HSV-1
keratitis revealed that the CXCL10 but not CXCL9 and CXCL11,
CXCR3 signaling axis plays a critical protective role in the mouse
model of viral keratitis [41, 42]. To determine if CXCL10 primar-
ily works as a fungicidal molecule, or as a chemokine that acts
through its engagement with CXCR3, we used anti-CXCL10 or
anti-CXCR3 antibodies and found that neutralizing either CXCL10
or CXCL3 resulted in significantly higher fungal load and greater
inflammation than the control. Surprisingly, neutralizing CXCR3
resulted in a greater increase in fungal burden in both the control
and flagellin-pretreated corneas, suggesting that CXCL10-
mediated signaling and/or recruitment are more important than
its fungicidal activity at 1 dpi. Our results differ from what has
been reported in a murine model of inhalational anthrax infection,
where the neutralization of CXCL10, but not its receptor CXCR3,
increased bacterial burden [36], suggesting that CXCL10 acts as
an important AMP in the anthrax infection model. Importantly,
neutralizing CXCL10 or CXCR3 impaired, but did not abolish,
flagellin-induced protection, suggesting that CXCL10-independent
effects of flagellin, including the augmented expression of other
AMPs, such as CRAMP and defensins, and the presence of innate
immune cells such as PMN at the time of pathogen–host interac-
tion [14, 19]. The effects of neutralizing CXCR3 on the severity of
CA keratitis is likely due to the effects of CXCL10-mediated recruit-
ment of professional innate immune cells. Indeed, we observed
greatly increased NK cells in CA-infected corneas 24 hpi. By this
time, a large number of CXCR3-positive cells were detected in
the control corneas, located mostly at the posterior side, while
CXCL10-positive cells were found both in the epithelial layer and
the stroma. As CECs are generally CXCR3-negative, the epithelial
cell-derived CXCL10 is likely to recruit other immune cells from
the limbal region rich in blood supply including macrophages and
NK cells. As such, it is of great interest to identify CXCR3 and/or
CXCL10 positive cells in CA-infected cells.
The staining pattern of NK1.1 is similar to CXCR3 in
CA-infected corneas, suggesting that the infiltrated CXCR3-
positive and/or CXCL10high cells are indeed NK or NK T cells. Our
study using Rag1KO mice ruled out the involvement of NK T cells.
Hence we concluded that the CXCR3-positive cells in CA-infected
cornea are indeed NK cells. Interestingly, the NK1.1-positive cells
are also CXCL10-positive, suggesting a possible autocrine signal-
ing in the recruited NK cells. Alternatively, CXCL10 expressed by
the epithelium binds to CXCR3 on the surface of the NK cells,
resulting in CXCL10high cells. In the CA-infected cornea, the cells
expressing abundant CXCL10 and CXCR3 were found to form
densely packed clusters on the top of and underneath the thin
epithelial layer in a lesion (infection) site. These cells are also pos-
itively stained with NK1.1. We postulate that NK cells surround
invading CA to form densely packed clusters in which CA were
eradicated. This is consistent with a recent report showing human
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NK cells are capable of ingesting CA, resulting in their activation
and in killing these microbes by secreting perforin [43]. Moreover,
the activated NK cells may also be indirectly involved in fungal
clearance by modulating neutrophil antifungal activity [43]. It is
interesting to note that when NK cells are neutralized, there are
more neutrophils present and severe tissue damage (Fig. 6), sim-
ilar to that observed in dextran sodium sulfate induced colitis in
mice [44]. One potential role of NK cells is to regulate neutrophil
function in a context-dependent manner: NK cells are activated
upon encountering CA and activate neutrophils [43]; when CA
are being eliminated by NK-cell released perforin [43] and/or by
NK-activated neutrophils, NK cells may induce neutrophil apopto-
sis [45]. In addition, NK cells may also participate in tissue repair
in the cornea as demonstrated recently in the epithelial wound
model [46, 47]. Consistent with NK cells as a critical component
of innate immunity, our NK-cell depletion study revealed severe
keratitis in the absence of NK cells, including corneal ulcers and
potential fungal dissemination to the anterior chamber. The other
known effectors cells are neutrophils, which we have shown to
be critical for flagellin-induced protection [14, 19]. Recent stud-
ies showed that a unique population of BM neutrophils produce
and respond to IL-17 [48, 49]. These neutrophils can be induced
to produce ROS in response to IL-17, resulting in an increase in
fungal killing in vitro and in a model of Aspergillus-induced kerati-
tis. These studies suggest a role of IL-17 in corneal innate defense
[48, 49]. The mechanisms underlying NK recruitment, activation,
fungicidal activity, and their interaction with other immune, par-
ticularly neutrophils, and residential cells in response to infection
are under investigation in our laboratories.
Finally, we tested the therapeutic potential of CXCL10 and
demonstrated that the administration of this chemokine prior to
pathogen inoculation significantly alleviated CA keratitis. More
importantly, the topical application of CXCL10 at 6 hpi was
still effective in accelerating the resolution of infection-associated
inflammation and in inhibiting infection and inflammation
induced hem- and lymphangiogenesis (Gao and Yu, unpublished
results). Hence, CXCL10 has the potential to be used as an adjunc-
tive therapy to reduce microbial keratitis-induced tissue damage.
Materials and methods
Fungi
CA strain SC5314, a clinical isolate capable of producing exper-
imental keratomycosis, was cultured on YPD agar (Sigma) for
3 days at 25°C. Colonies were harvested after 3 days of inocula-
tion and diluted in sterile PBS to yield 2 × 105 CFU/μL based on
the OD at 600 nm, using a predetermined OD600 conversion factor
of 1 OD = 3 × 107 CFU/mL [15].
Animals
WT C57BL/6 mice (8 weeks of age; 20–24 g weight) were used.
C57BL/6.129S7-Rag1tm1Mom/J (Rag1−/−, 8 weeks females with
C57BL/6 females as the control) were purchased from the Jack-
son Lab. Animals were treated in compliance with the ARVO
Statement on the Use of Animals in Ophthalmic and Vision
Research. The Institutional Animal Care and Use Committee of
Wayne State University approved all animal procedures.
Flagellin preparation, pretreatment, and infection
procedure
Flagellin was prepared from P. aeruginosa strain PA01 as
described earlier [16, 50]. The bioactivity of each preparation was
compared with previous samples for their ability to induce tol-
erance in cultured human CECs [51]. For flagellin pretreat-
ment, mice (n = 5/group/treatment) were anesthetized with
ketamine/xylazine and placed beneath a stereoscopic microscope
at a magnification of 40×, and the corneas were scratched gently
with three 1 mm incisions using a sterile 26-gauge needle. Puri-
fied flagellin (500 ng in 5 μL of PBS) or PBS for the control was
applied to the injured corneas of the same mice (one serves as
the control for the other; the data were presented as the num-
ber of eyes). After 24 h, corneas were excised and processed for
CXCL10 and CXCR3 expression. For corneal infection, mice were
anesthetized, the pretreated corneas were rescratched 24 h post-
flagellin application, and a 5 μL suspension containing a 1 × 105
CFU of CA strain SC5314 was applied to the surface of the scarified
cornea. The anesthetized mice were kept on a fixed position with
the instilled solution remaining on the ocular surface until they
awakened (usually >20 min).
Clinical scoring
For the assessment of clinical scores, the mice were color-coded
and examined by two independent observers daily, one with the
knowledge of codes and the other in a blind fashion, and pho-
tographed at 1, 3, 5, or 7 days after infection (dpi). If there was a
conflict in clinical scoring, a third person, usually the correspond-
ing author, would perform scoring from photographs. Ocular
disease was graded in clinical scores ranging from 0 to 12, accord-
ing to the scoring system developed by Wu et al. [52]. A grade of
0–4 was assigned to each of the following three criteria—area of
opacity, density of opacity, and surface irregularity—resulting in
a potential total score of 12. At the indicated time, all infected
corneas were photographed with a slide lamp or a dissection
microscope to illustrate the disease progression.
Fungal load determination, cytokine ELISA, and MPO
measurement
We used our previously modified methods that allowed all three
assays (fungal load, MPO determination, and cytokine ELISA mea-
surement) to be performed with a single mouse cornea. Briefly,
the corneas were excised from the enucleated eyes, minced, and
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homogenized in 100 μL PBS. The homogenates were divided
into two parts, one for plate fungal counting and the other for
cytokine ELISA and MPO measurements [14]. In each experi-
ment, the controls without flagellin pretreatment were expected
to have 2000–5000 CFU recovered, while flagellin pretreatment
eradicated invading pathogens (<10 CFU/cornea) at 1 dpi.
RT-PCR and real-time PCR
Mouse cornea RNA was extracted using RNeasy Mini Kit (Qiagen),
according to the manufacturer’s instructions. cDNA was generated
with an oligo(dT) primer (Invitrogen) followed by analysis using
real-time PCR with the Power SYBR Green PCR Master Mix (AB
Applied Biosystems, University Park, IL) based on the expression
of β-actin. Generated cDNA was amplified by PCR by using
primers for mouse Cxcl10, Cxcr3, and β-actin. The PCR products
and the internal control β-actin were subjected to electrophoresis
on 1% agarose gels containing ethidium bromide. Stained
gels were captured by using a digital camera. The following
primer pairs were used: 5′-GACGGCCAGGTCATCACTATTG-3′,
5′-AGGAAGGCTGGAAAAGAGCC-3′ for β-actin, 5′-CCATCAGCA
CCATGAACCCAAGT-3′, 5′-CACTCCAGTTAAGGAGC-3′ for
Cxcl10, 5′-GATCAAACCTGCCTAGATCC-3′, 5′-GGCTGTGTAGA
ACACAGAGT-3′ for Cxcl9, 5′-ATTACCAGGCTGCAGAACTTT-3′,
5′-TCTTCCTAGATGTTCGTGTGC-3′ for Cxcl11, and 5′-AGAATC
ATCCTGGTCTGAGACAA-3′, 5′-AAGATAGGGCATGGCAGCTA-3′
for Cxcr3.
Immunohistochemistry
At the indicated times, the corneas were excised from sacrificed
mice and were frozen in Optimal Cutting Temperature (OCT)
compound; posterior parts along with the lens were removed
after the global parts were just frozen. The corneas were cut into
6 μm thick sections by cryostat sectioning and the sections were
mounted to polylysine-coated glass slides. After a 10 min fixation
in 4% paraformaldehyde, the sections were blocked with 10 mM
PBS, containing 2% BSA, for 1 h at room temperature. Sections
were then incubated with primary antibodies: rabbit anti-mouse
CXCL10 (Peprotech; 1:100), CXCR3 (Abnova, 1:250), followed by
the secondary Ab, Cy3-conjugated goat anti-rabbit IgG (Jackson
Immunoresearch Inc), with or without FITC-labeled anti-mouse
NK1.1 (eBiosciences; 1:100). Slides were mounted with DAPI
mounting media. Controls were similarly treated, but the primary
Ab was replaced with nonspecific rabbit IgG.
CXCL10, CXCR3, and NK1.1 neutralization
Mice were anesthetized as prescribed and rabbit anti-
murine CXCL10 or CXCR3, anti-mouse NK1.1 (clone PK136)
(2.5 μg/5 μL, Abnova) were injected subconjunctivally,
2.5 μg/5μL, 6 h before CA infection.
In vitro assay of antifungal activity of recombinant
CXCL10
For recombinant CXCL10, 400 μL PBS with different concen-
trations of recombinant mouse CXCL10 were incubated with
1 × 104 CFU CA at 37°C for 2 h. Serial dilutions of each reac-
tion mixture were made to inoculate YPD agar plates. Samples
(100 μL) were spread evenly over the surface of the plates with
sterile glass spreaders. After incubation at 25°C for 72 h, the
number of colonies was counted. Experiments were repeated
once.
To determine whether CECs expressing CXCL10 possessed
fungicidal activity, HUCL cells (a human CEC line [53]) were
cultured on 12-well tissue culture plates (Costar), and then were
transfected with 1.5 × 1011 CFU AAV2 (recombinant adeno-
associated virus vector-2) with inserted DNA that encoded the
human CXCL10 with green fluorescence protein as the control
(a gift from Dr. Xiao Xiao, University of North Carolina at Chapel
Hill). The transfected cells expressed high levels of the target genes
at day 3. At day 3 post-AAV2 infection, cells were cultured in 1 mL
fresh defined keratinocyte—a serum-free medium (Invitrogen-Life
Technologies, Carlsbad, CA)—for 24 h and the culture media were
then collected and used for in vitro assay of antifungal activities
as described for recombinant CXCL10.
Statistical analysis
Data were presented as the means ± SD. Statistical differences
among three or more groups were identified using one-way
ANOVA. Differences were considered statistically significant at
p < 0.05. Between two groups, an unpaired, two-tailed Student’s
t-test was used to determine statistical significance for data from
fungal counts, cytokine ELISA, and the MPO assay. A nonparamet-
ric Mann–Whitney U-test was performed to determine statistical
significance for clinical scores. Experiments were repeated at least
twice to ensure reproducibility.
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